Financial Data and Key Metrics Changes - Q2 revenue was €38,300,000, up 2% compared to the previous quarter but down 22% from a record high in Q2 last year [5][29] - Gross margin was 37.8%, stable compared to the previous quarter and within the guided range of 37% to 39% [7][30] - Adjusted EBITDA loss for Q2 was €7,500,000, reflecting a 33% improvement year over year [10][32] - Cash costs, defined as labor costs and operating expenses excluding R&D, decreased by 35% year over year [9][31] Business Line Data and Key Metrics Changes - AC sales generated €26,600,000, representing approximately 69% of total revenue, with a 4% improvement quarter over quarter but down 18% year over year [15] - DC sales remained flat at €4,200,000, contributing 11% to total sales, with expectations for improvement in upcoming quarters [17] - Software and services grew by 27% year over year, generating €7,600,000 or 20% of total revenue [20] Market Data and Key Metrics Changes - Europe contributed €26,100,000 or 68% of total revenue, with a 30% year-over-year growth in the European EV market [12][24] - North America contributed €11,400,000 or 30% of total revenue, with a 5% year-over-year decline in the EV market [13][25] - APAC and LATAM contributed approximately €260,000 and €550,000 respectively, with significant future potential but not prioritized currently [14] Company Strategy and Development Direction - The company aims to selectively invest in sales structures to capture renewed market growth, particularly in Europe and North America [6][12] - Focus on operational efficiency and rightsizing the organization to achieve profitability while maintaining growth [10][28] - The company is leveraging its platform and innovative product portfolio to position itself as a leader in the EV market [36] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in potential growth in the second half of the year, driven by the recovery of the European EV market [36] - The company recognizes the volatility in the North American market due to changing subsidies and policies but remains optimistic about growth opportunities [25][26] - The strategic focus is on adapting to market dynamics and achieving profitability through a flexible organizational structure [27][28] Other Important Information - The company ended the quarter with approximately €32,400,000 in cash and financial instruments, with total debt increasing by 9% to €182,000,000 [33][34] - Inventory decreased by 33% year over year, reflecting operational improvements [35] Q&A Session Summary Question: Status of the Generac investment - Management confirmed that the partnership with Generac is progressing well, with home chargers being commercialized in North America and integration of app platforms [41][42] Question: Details about the QUASAR two project - Management highlighted that QUASAR two is a bidirectional charger allowing electric car batteries to power homes, with initial deliveries to Kia AV9 owners [46][48] Question: Updates on the ABL acquisition and market momentum - Management reported strong growth in Germany and Spain, with a focus on expanding the sales organization and cross-selling opportunities [59][60]

Market Overview - The market in 2025 is characterized by uncertainty driven by tariffs, interest rates, and inflation, presenting opportunities for investors with cash on the sidelines [1] - Analysts have adjusted their expectations post-earnings season, with some upgrading stocks they previously viewed as bearish, often leading to higher price targets [1][2] Advance Auto Parts (AAP) - Advance Auto Parts has a 12-month stock price forecast of $46.01, indicating an 11.88% downside from the current price of $52.21 [3] - Analysts are beginning to view AAP more favorably, with Redburn Partners upgrading the stock from Sell to Neutral and raising the price target from $28 to $45 due to strengthening fundamentals [4] - AAP is seen as a potential asymmetric play for investors, especially as competitors like AutoZone and O'Reilly are trading at historically high valuations [5] BioLineRx (BLRX) - BioLineRx has a 12-month stock price forecast of $26.00, suggesting a significant upside of 362.63% from the current price of $5.62 [6][7] - The stock was recently upgraded from Hold to Strong Buy by Jones Trading, driven by the completion of the transfer of U.S. commercial rights for its drug APHEXDA, allowing the company to focus on its oncology pipeline [8] - BioLineRx's equity stake in the partnership with Ayrmid Bio reduces cash burn risks while enabling milestone payments and royalties [9] Anheuser-Busch InBev (BUD) - Anheuser-Busch InBev has a 12-month stock price forecast of $71.50, indicating a slight upside of 0.68% from the current price of $71.02 [10] - Despite pressures from inflation and changing consumer habits, BUD's strong brand portfolio and growth in non-alcoholic beer categories are helping to boost sales [12] - Following a recent earnings report, BNP Paribas upgraded BUD from Hold to Strong Buy, highlighting the company's ability to beat earnings per share estimates despite a slight revenue miss [13]